166 related articles for article (PubMed ID: 9765729)
1. Tamoxifen and breast cancer prevention: are we aware of the risks?
Mandeville R; Houde M
Cancer Prev Control; 1997; 1(1):66-72. PubMed ID: 9765729
[No Abstract] [Full Text] [Related]
2. Tamoxifen Breast Cancer Prevention Trial--an update.
Ford LG; Johnson KA
Prog Clin Biol Res; 1997; 396():271-82. PubMed ID: 9108604
[No Abstract] [Full Text] [Related]
3. Tamoxifen for the prevention of breast cancer.
Greenspan EM
Am J Med; 1996 Jun; 100(6):665. PubMed ID: 8678089
[No Abstract] [Full Text] [Related]
4. Tamoxifen for breast cancer prevention.
Force RW
J Fam Pract; 1998 Nov; 47(5):336-7. PubMed ID: 9834765
[No Abstract] [Full Text] [Related]
5. Preventing breast cancer with tamoxifen.
Health News; 1998 May; 4(6):1, 5. PubMed ID: 9602560
[No Abstract] [Full Text] [Related]
6. Tamoxifen for breast cancer prevention.
Jpn J Clin Oncol; 1998 Dec; 28(12):775-6. PubMed ID: 9879301
[No Abstract] [Full Text] [Related]
7. Tamoxifen for prevention of breast cancer.
Med Lett Drugs Ther; 1999 Jan; 41(1043):1-2. PubMed ID: 9924486
[No Abstract] [Full Text] [Related]
8. Tamoxifen in cancer therapy: minireview.
Novotny L; Rauko P; Vachálková A; Peterson-Biggs M
Neoplasma; 2000; 47(1):3-7. PubMed ID: 10870680
[TBL] [Abstract][Full Text] [Related]
9. Design of an ideal hormone replacement therapy for women.
Tonetti DA; Jordan VC
Mol Carcinog; 1996 Nov; 17(3):108-11. PubMed ID: 8944069
[No Abstract] [Full Text] [Related]
10. Should you be taking tamoxifen?
Johns Hopkins Med Lett Health After 50; 2001 Jun; 13(4):4-5. PubMed ID: 11439691
[No Abstract] [Full Text] [Related]
11. Prevention of breast cancer in high-risk women.
Kardinal CG; Veith R
J La State Med Soc; 1999 Apr; 151(4):198-201. PubMed ID: 10234895
[TBL] [Abstract][Full Text] [Related]
12. [Chemoprevention of breast cancer. Impact of a new therapeutic strategy].
Kattan J; Ghosn M
J Med Liban; 1999; 47(5):284-5. PubMed ID: 10887527
[No Abstract] [Full Text] [Related]
13. Tamoxifen for breast cancer prevention: safety warning.
Wooltorton E
CMAJ; 2002 Aug; 167(4):378-9. PubMed ID: 12197698
[No Abstract] [Full Text] [Related]
14. Chemoprevention of breast cancer: recommendations and rationale.
Am Fam Physician; 2003 Mar; 67(6):1309-14. PubMed ID: 12674459
[No Abstract] [Full Text] [Related]
15. Mechanisms of tamoxifen resistance.
Ring A; Dowsett M
Endocr Relat Cancer; 2004 Dec; 11(4):643-58. PubMed ID: 15613444
[TBL] [Abstract][Full Text] [Related]
16. Clear thinking on tamoxifen.
Johns Hopkins Med Lett Health After 50; 1998 Jul; 10(5):1-2. PubMed ID: 9650523
[No Abstract] [Full Text] [Related]
17. Chemoprevention of breast cancer for women at high risk.
Chan K; Morris GJ
Semin Oncol; 2006 Dec; 33(6):642-6. PubMed ID: 17145342
[TBL] [Abstract][Full Text] [Related]
18. Is there any association between uterine malignant mixed Mullerian tumour, breast cancer and prolonged tamoxifen treatment?
Moe MM; El-Sharkawi S
J Obstet Gynaecol; 2003 May; 23(3):301-3. PubMed ID: 12850867
[TBL] [Abstract][Full Text] [Related]
19. Chemoprevention of breast cancer.
Dalton RR; Kallab AM
South Med J; 2001 Jan; 94(1):7-15. PubMed ID: 11213947
[TBL] [Abstract][Full Text] [Related]
20. Association between Pak1 expression and subcellular localization and tamoxifen resistance in breast cancer patients.
Holm C; Rayala S; Jirström K; Stål O; Kumar R; Landberg G
J Natl Cancer Inst; 2006 May; 98(10):671-80. PubMed ID: 16705121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
